Brief: Eyepoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule
16/12/2024 12:24
Dec 16 (Reuters) - EyePoint Pharmaceuticals Inc
EYPT.O :
* EYEPOINT PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER
NASDAQ
LISTING RULE 5635(C)(4)
Source text: ID:nGNX15ttBX
Further company coverage: EYPT.O
Recent news on EyePoint
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
US STOCKS ON THE MOVE-CoreWeave, Moderna, Datadog
U.S. STOCKS ON THE MOVE-Amazon, CoreWeave, Moderna
U.S. STOCKS ON THE MOVE-Centrus Energy, Disc Medicine, Crypto
EyePoint to halve workforce after experimental drug fails second late-stage trial (updated)